Simulating Serial-Target Antibacterial Drug Synergies Using Flux Balance Analysis: e0147651

Flux balance analysis (FBA) is an increasingly useful approach for modeling the behavior of metabolic systems. However, standard FBA modeling of genetic knockouts cannot predict drug combination synergies observed between serial metabolic targets, even though such synergies give rise to some of the...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2016-01, Vol.11 (1)
Main Authors: Krueger, Andrew S, Munck, Christian, Dantas, Gautam, Church, George M, Galagan, James, Lehar, Joseph, Sommer, Morten OA
Format: Article
Language:English
Subjects:
Escherichia coli
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Flux balance analysis (FBA) is an increasingly useful approach for modeling the behavior of metabolic systems. However, standard FBA modeling of genetic knockouts cannot predict drug combination synergies observed between serial metabolic targets, even though such synergies give rise to some of the most widely used antibiotic treatments. Here we extend FBA modeling to simulate responses to chemical inhibitors at varying concentrations, by diverting enzymatic flux to a waste reaction. This flux diversion yields very similar qualitative predictions to prior methods for single target activity. However, we find very different predictions for combinations, where flux diversion, which mimics the kinetics of competitive metabolic inhibitors, can explain serial target synergies between metabolic enzyme inhibitors that we confirmed in Escherichia coli cultures. FBA flux diversion opens the possibility for more accurate genome-scale predictions of drug synergies, which can be used to suggest treatments for infections and other diseases.
ISSN:1932-6203
DOI:10.1371/journal.pone.0147651